BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 29528815)

  • 21. A review of neuroblastoma image-defined risk factors on magnetic resonance imaging.
    Chen AM; Trout AT; Towbin AJ
    Pediatr Radiol; 2018 Aug; 48(9):1337-1347. PubMed ID: 30078048
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroblastoma and other neuroendocrine tumors.
    Howman-Giles R; Shaw PJ; Uren RF; Chung DK
    Semin Nucl Med; 2007 Jul; 37(4):286-302. PubMed ID: 17544628
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroblastoma, ganglioneuroblastoma, and ganglioneuroma: radiologic-pathologic correlation.
    Lonergan GJ; Schwab CM; Suarez ES; Carlson CL
    Radiographics; 2002; 22(4):911-34. PubMed ID: 12110723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuroblastoma: biology and therapy.
    Matthay KK
    Oncology (Williston Park); 1997 Dec; 11(12):1857-66; discussion 1869-72, 1875. PubMed ID: 9436190
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuroblastoma: an enigmatic disease.
    Brossard J; Bernstein ML; Lemieux B
    Br Med Bull; 1996 Oct; 52(4):787-801. PubMed ID: 9039732
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MIBG in Neuroblastoma Diagnostic Imaging and Therapy.
    Sharp SE; Trout AT; Weiss BD; Gelfand MJ
    Radiographics; 2016; 36(1):258-78. PubMed ID: 26761540
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroblastoma: Therapeutic strategies for a clinical enigma.
    Modak S; Cheung NK
    Cancer Treat Rev; 2010 Jun; 36(4):307-17. PubMed ID: 20227189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pediatrics: diagnosis of neuroblastoma.
    Sharp SE; Gelfand MJ; Shulkin BL
    Semin Nucl Med; 2011 Sep; 41(5):345-53. PubMed ID: 21803184
    [TBL] [Abstract][Full Text] [Related]  

  • 29. N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: results of the French NBL 90 study. Neuroblastoma Study Group of the Société Francaise d'Oncologie Pédiatrique.
    Rubie H; Hartmann O; Michon J; Frappaz D; Coze C; Chastagner P; Baranzelli MC; Plantaz D; Avet-Loiseau H; Bénard J; Delattre O; Favrot M; Peyroulet MC; Thyss A; Perel Y; Bergeron C; Courbon-Collet B; Vannier JP; Lemerle J; Sommelet D
    J Clin Oncol; 1997 Mar; 15(3):1171-82. PubMed ID: 9060561
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroblastoma in the adult. Case report.
    Zerrweck-López C; Quijano-Orvañanos F; Montañez-Ramírez H; Murillo-Zolezzi A; Toledo-Valdovinos S; Padilla-Longoria R
    Cir Cir; 2009; 77(5):397-401. PubMed ID: 19944030
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Favorable biology and outcome of stage IV-S neuroblastoma with supportive care or minimal therapy: a Children's Cancer Group study.
    Nickerson HJ; Matthay KK; Seeger RC; Brodeur GM; Shimada H; Perez C; Atkinson JB; Selch M; Gerbing RB; Stram DO; Lukens J
    J Clin Oncol; 2000 Feb; 18(3):477-86. PubMed ID: 10653863
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Successful treatment of stage III neuroblastoma based on prospective biologic staging: a Children's Cancer Group study.
    Matthay KK; Perez C; Seeger RC; Brodeur GM; Shimada H; Atkinson JB; Black CT; Gerbing R; Haase GM; Stram DO; Swift P; Lukens JN
    J Clin Oncol; 1998 Apr; 16(4):1256-64. PubMed ID: 9552023
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ten challenges in the management of neuroblastoma.
    Gains J; Mandeville H; Cork N; Brock P; Gaze M
    Future Oncol; 2012 Jul; 8(7):839-58. PubMed ID: 22830404
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Image-defined Risk Factors Correlate with Surgical Radicality and Local Recurrence in Patients with Neuroblastoma.
    Pohl A; Erichsen M; Stehr M; Hubertus J; Bergmann F; Kammer B; von Schweinitz D
    Klin Padiatr; 2016 Apr; 228(3):118-23. PubMed ID: 26930233
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Management strategy in neuroblastoma].
    Balwierz W
    Przegl Lek; 2004; 61 Suppl 2():3-8. PubMed ID: 15686038
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Localized infant neuroblastomas often show spontaneous regression: results of the prospective trials NB95-S and NB97.
    Hero B; Simon T; Spitz R; Ernestus K; Gnekow AK; Scheel-Walter HG; Schwabe D; Schilling FH; Benz-Bohm G; Berthold F
    J Clin Oncol; 2008 Mar; 26(9):1504-10. PubMed ID: 18349403
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroblastoma.
    Angstman KB; Miser JS; Franz WB
    Am Fam Physician; 1990 Jan; 41(1):238-44. PubMed ID: 2403727
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Occurrence and prognostic impact of selected factors in neuroblastoma in children].
    Wieczorek A; Balwierz W
    Przegl Lek; 2010; 67(6):393-8. PubMed ID: 21344768
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comprehensive protocol for diagnosis and treatment of childhood neuroblastoma--results of 45 cases].
    Tang JY; Pan C; Chen J; Xu M; Chen J; Xue HL; Gu LJ; Dong R; Ye H; Zhou M; Wang YP
    Zhonghua Er Ke Za Zhi; 2006 Oct; 44(10):770-3. PubMed ID: 17229383
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroblastoma: a review of management and outcome.
    Bhatnagar SN; Sarin YK
    Indian J Pediatr; 2012 Jun; 79(6):787-92. PubMed ID: 22528697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.